id: NEW:slc6a3_gene_polymorphism_rs28363170_to_NEW:personality_disorder_diagnosis
name: SLC6A3 Gene Polymorphism (rs28363170 9-repeat allele) â†’ Personality Disorder Diagnosis
from_node:
  node_id: NEW:slc6a3_gene_polymorphism_rs28363170
  node_name: SLC6A3 Gene Polymorphism (rs28363170 9-repeat allele)
to_node:
  node_id: NEW:personality_disorder_diagnosis
  node_name: Personality Disorder Diagnosis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Individuals carry the rs28363170 polymorphism with 9-repeat allele variant in the SLC6A3 (dopamine
  transporter) gene'
- 'Step 2: This genetic variant affects dopamine transporter expression and function, altering dopaminergic
  neurotransmission'
- 'Step 3: Dysregulated dopamine signaling impacts reward processing, impulse control, and emotional regulation
  circuits'
- 'Step 4: These neurobiological alterations contribute to the development of socially dysfunctional behavioral
  patterns characteristic of personality disorders'
evidence:
  quality_rating: A
  n_studies: 9
  primary_citation: 'Angeliki V Vogiatzoglou et al. 2024. "Genetic association of SLC6A3 (dopamine transporter)
    gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and
    meta-analysis.." https://doi.org/10.1097/YPG.0000000000000375'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis included 9 studies with 729 cases and
    2113 controls
  - Studies examining dopaminergic pathway gene variants in personality disorders (per abstract background)
  - Family-based studies documenting higher incidence rates of personality disorders within families (per
    abstract)
  doi: 10.1097/YPG.0000000000000375
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: This systematic review and meta-analysis found a statistically significant association between
  the SLC6A3 gene polymorphism rs28363170 (specifically the 9-repeat allele) and personality disorders
  in European populations under co-dominant inheritance. The dopamine transporter gene variant affects
  dopaminergic neurotransmission, which is implicated in the neurobiological mechanisms underlying personality
  disorders.
quantitative_effects:
  sample_size: 2842
spatial_variation:
  varies_by_geography: true
  variation_notes: Statistically significant association was observed specifically in European populations,
    suggesting population-specific genetic effects
moderators:
- name: ancestry_population
  direction: strengthens
  strength: strong
  description: Association was significant in European populations but may differ in other ancestral groups
- name: mode_of_inheritance
  direction: strengthens
  strength: moderate
  description: Association was significant under co-dominant mode of inheritance
structural_competency:
  equity_implications: 'While this mechanism is primarily biological/genetic, structural factors influence
    how genetic vulnerabilities manifest: access to mental healthcare, diagnostic disparities across populations,
    and socioeconomic factors that determine whether genetic predispositions lead to clinical disorders.
    The finding of population-specific effects (European ancestry) highlights the need for diverse representation
    in genetic research. Understanding genetic contributions should inform personalized medicine approaches
    rather than deterministic views, and should not obscure the role of structural factors in mental health
    outcomes.'
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.959877'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
